Hybrid particle immunogens

Details Hybrid particle immunogens Hybrid particle immunogens

C - Chemistry, Metallurgy

07

K

167/130, 195/1.2

C07K 14/02 (2006.01) A61K 39/29 (2006.01) C07K 14/035 (2006.01) C07K 14/445 (2006.01) C12N 15/62 (2006.01) C12N 15/81 (2006.01)

Patent

CA 1263618

HYBRID PARTICLE IMMUNOGENS ABSTRACT OF THE DISCLOSURE Novel immunogenic compositions are provided involving viral particles composed at least in part of hybrid proteins of at least a portion of a particle forming protein and one or more polypeptides having at least one epitope of interest. Nucleic acid sequences are employed coding for the hybrid protein which are introduced into a host cell for expression, either by themselves or in combination with other DNA sequences coding for particle forming proteins. Expression of the DNA sequences results in formation of particles which may be isolated and used as immunogens for production of antibodies for diagnostics purposes, passive immunization, vaccination, or other uses. Saccharomyces carlsbergensis, 2150-2-3 (pDC103), was deposited on September 7, 1984, at the ATCC and given ATCC Accession No. 20726. Also, Saccharomyces cerevisiae PO17 (pC1/l-MCS29) was deposited at the ATCC on 5 September _, 1985, and given ATCC Accession No.2077Q CCCCC8/9729-37-1F

490607

Affiliated with

Also associated with

Rating

Hybrid particle immunogens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybrid particle immunogens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid particle immunogens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1309144